Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tadalafil and Pembrolizumab in Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma
NCT03993353Phase 2Completed
- Sponsor
- University of California, San Diego
- Start
- Apr 2020
- Primary completion
- Apr 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of tadalafil in head and neck squamous cell carcinoma (HNSCC), sponsored by University of California, San Diego. Started Apr 2020; status: completed.
02
Drugs
tadalafil
03
Conditions
head and neck squamous cell carcinoma (HNSCC)
Beyond the preview
Go deeper on NCT03993353.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03993353.